Latest filing published 18 May 2022 for Egetis Therapeutics AB (publ), €668k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Peder Walberg: trading record in brief
Peder Walberg appears in our data through filings on Egetis Therapeutics AB (publ) shares, published by Finansinspektionen. In total, 4 filings cover trades dated from 3 November 2020 to 17 May 2022.
On the open market, the record shows 2 purchases worth €16.8M and 2 sales. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2022 to date brings 1 purchase and 2 sales.
The newest entry dates from 18 May 2022: an open-market purchase of €668k, in Egetis Therapeutics AB (publ). Filings reach the Finansinspektionen feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peder Walberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,917,807 shares@ SEK 3.654.0% of flowBTA (betald tecknad aktie)ISIN SE0017770027FI:csv-7aa995d2f6775589e153Canonical exit: 15 Aug 2022 (T+90)
- 319,620 shares0Teckningsrätt/UniträttISIN SE0017770019FI:csv-957dd39493dea28e3b00
- 25,146,104 shares0Teckningsrätt/UniträttISIN SE0017770019FI:csv-25654638b608fdc48aff
- 31,858,414 shares@ SEK 5.25100.0% of flowAktieISIN SE0003815604FI:csv-2cbcf70fa3f45c480cf1Canonical exit: 1 Feb 2021 (T+90)
4 of 4 declarations